PURPOSE: To analyze the expansion of CTG18.1 allele associated with Fuchs' corneal dystrophy (FCD) in our large cohort of late-onset FCD cases. METHODS: CTG repeats within the CTG18.1 allele were estimated by short tandem repeat (STR) and triplet primed PCR (TP-PCR) assays in our large cohort of 574 late-onset FCD cases and 354 controls and large multigeneration familial cases. The age versus severity relationships were analyzed in FCD genotypes, namely, nonexpanded (N/N), monoallelic expansion (N/X), and biallelic expansion (X/X) with N ≤ 40 CTG monomers. The threshold for causality conferred by an expansion of CTG18.1 was identified by excluding the population of FCD cases who harbored an allele length equivalent to the maximum CTG monomers observed in the controls. RESULTS: The expanded CTG18.1 for (CTG)n>40 showed a strong association (P = 1.56 × 10(-82)) with FCD. Importantly, we delineated the threshold of expansion to 103 CTG repeats above which the allele confers causality in 17.8% of FCD cases. Regression analyses demonstrated a significant correlation between disease severity and age in individuals who harbor either a monoallelic expansion or a biallelic expansion at (CTG) n > 40. These analyses helped predict FCD in two previously unaffected individuals based on their CTG18.1 expansion genotype. CONCLUSIONS: A monoallelic expansion of CTG18.1 contributes to increased disease severity and is causal at (CTG)n>103, whereas a biallelic expansion is sufficient to be causal for FCD at (CTG)n>40. This study highlights the largest contributory causal allele for FCD.
PURPOSE: To analyze the expansion of CTG18.1 allele associated with Fuchs' corneal dystrophy (FCD) in our large cohort of late-onset FCD cases. METHODS:CTG repeats within the CTG18.1 allele were estimated by short tandem repeat (STR) and triplet primed PCR (TP-PCR) assays in our large cohort of 574 late-onset FCD cases and 354 controls and large multigeneration familial cases. The age versus severity relationships were analyzed in FCD genotypes, namely, nonexpanded (N/N), monoallelic expansion (N/X), and biallelic expansion (X/X) with N ≤ 40 CTG monomers. The threshold for causality conferred by an expansion of CTG18.1 was identified by excluding the population of FCD cases who harbored an allele length equivalent to the maximum CTG monomers observed in the controls. RESULTS: The expanded CTG18.1 for (CTG)n>40 showed a strong association (P = 1.56 × 10(-82)) with FCD. Importantly, we delineated the threshold of expansion to 103 CTG repeats above which the allele confers causality in 17.8% of FCD cases. Regression analyses demonstrated a significant correlation between disease severity and age in individuals who harbor either a monoallelic expansion or a biallelic expansion at (CTG) n > 40. These analyses helped predict FCD in two previously unaffected individuals based on their CTG18.1 expansion genotype. CONCLUSIONS: A monoallelic expansion of CTG18.1 contributes to increased disease severity and is causal at (CTG)n>103, whereas a biallelic expansion is sufficient to be causal for FCD at (CTG)n>40. This study highlights the largest contributory causal allele for FCD.
Authors: C L Liquori; K Ricker; M L Moseley; J F Jacobsen; W Kress; S L Naylor; J W Day; L P Ranum Journal: Science Date: 2001-08-03 Impact factor: 47.728
Authors: Laura J Kopplin; Katie Przepyszny; Brian Schmotzer; Karen Rudo; Denise C Babineau; Sanjay V Patel; David D Verdier; Ula Jurkunas; Sudha K Iyengar; Jonathan H Lass Journal: Arch Ophthalmol Date: 2012-04
Authors: Allen O Eghrari; Elyse J McGlumphy; Benjamin W Iliff; Jiangxia Wang; David Emmert; S Amer Riazuddin; Nicholas Katsanis; John D Gottsch Journal: Am J Ophthalmol Date: 2012-02-08 Impact factor: 5.258
Authors: Eric D Wieben; Ross A Aleff; Bruce W Eckloff; Elizabeth J Atkinson; Saurabh Baheti; Sumit Middha; William L Brown; Sanjay V Patel; Jean-Pierre A Kocher; Keith H Baratz Journal: Invest Ophthalmol Vis Sci Date: 2014-08-28 Impact factor: 4.799
Authors: Eric D Wieben; Ross A Aleff; Nirubol Tosakulwong; Malinda L Butz; W Edward Highsmith; Albert O Edwards; Keith H Baratz Journal: PLoS One Date: 2012-11-21 Impact factor: 3.240
Authors: Naoki Okumura; Ryousuke Hayashi; Masakazu Nakano; Kei Tashiro; Kengo Yoshii; Ross Aleff; Malinda Butz; Edward W Highsmith; Eric D Wieben; Michael P Fautsch; Keith H Baratz; Yuya Komori; Emi Ueda; Makiko Nakahara; Julia Weller; Theofilos Tourtas; Ursula Schlötzer-Schrehardt; Friedrich Kruse; Noriko Koizumi Journal: Cornea Date: 2019-07 Impact factor: 2.651
Authors: Allen O Eghrari; Shivakumar Vasanth; Jiangxia Wang; Farnoosh Vahedi; S Amer Riazuddin; John D Gottsch Journal: Cornea Date: 2017-01 Impact factor: 2.651
Authors: Arvis Sulovari; Ruiyang Li; Peter A Audano; David Porubsky; Mitchell R Vollger; Glennis A Logsdon; Wesley C Warren; Alex A Pollen; Mark J P Chaisson; Evan E Eichler Journal: Proc Natl Acad Sci U S A Date: 2019-10-28 Impact factor: 11.205
Authors: Allen O Eghrari; Marjohn M Rasooly; Michael J Fliotsos; Jessica Kinard; Obinna Odozor; Denise Cunningham; Rachel J Bishop; Anthony L Guerrerio; Pamela A Frischmeyer-Guerrerio Journal: Can J Ophthalmol Date: 2020-04-16 Impact factor: 1.882
Authors: Abraham Kuot; Alex W Hewitt; Grant R Snibson; Emmanuelle Souzeau; Richard Mills; Jamie E Craig; Kathryn P Burdon; Shiwani Sharma Journal: PLoS One Date: 2017-08-23 Impact factor: 3.240
Authors: Stephan Ong Tone; Viridiana Kocaba; Myriam Böhm; Adam Wylegala; Tomas L White; Ula V Jurkunas Journal: Prog Retin Eye Res Date: 2020-05-08 Impact factor: 21.198
Authors: Allen O Eghrari; Sina Vahedi; Natalie A Afshari; S Amer Riazuddin; John D Gottsch Journal: Invest Ophthalmol Vis Sci Date: 2017-12-01 Impact factor: 4.799